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Results: Of  the 43 patients included in the study, 20 were male, and the 
other 23 were female. The mean age of  all participants was 41.44 years 
(SD=15.89). Patients were taking the following antipsychotics and anti-
depressants: clozapine (n=6), amisulpride (n=9), aripiprazole (n=5), 
olanzapine (n=18), risperidone (n=1), quetiapine (n=20), haloperidol 
(n=1), paliperidone (n=5), chlorpromazine (n=1), blonanserin (n=1), 
escitalopram (n=7), sertraline (n=1), mirtazapine (n=2), duloxetine 
(n=1), venlafaxine (n=3), amitriptyline (n=1), trazodone (n=1), bupro-
pion (n=1). Participants took an average of  1.91 (SD=1.02, range 0–5) 
different psychotropic drugs during ECT. The mean number of  types 
of  antipsychotics and antidepressants used were 1.53 (SD=0.74, range 
0–3) and 0.37 (SD=0.76, range 0–4), respectively. Multivariate regres-
sion analyses showed positive correlations between initial ST and the 
total chlorpromazine-equivalent dose of  antipsychotics (β  =  0.363, 
p < 0.05). The total fluoxetine-equivalent dose of  antidepressants was 
positively correlated to ΔST10th (β = 0.486, p < 0.05) and mean ΔSTlast 
(β = 0.472, p < 0.01).
Discussion: Our study elucidated possible effects of psychotropic drugs on 
ST in patients undergoing ECT. We revealed that larger doses of antipsy-
chotics are associated with higher initial ST, whereas higher doses of anti-
depressants are associated with stronger shifts of ST during the course of 
treatment. We believe that our findings provide a basis for creating safer 
and more efficient ECT protocols.
S202. EFFICACY OF LONG-TERM RESIDENTIAL 
TREATMENT FOR PERSISTENT MENTAL 
ILLNESS
Michael Knable*,1
1Sylvan C. Herman Foundation
Background: In the United States, the number of public and private psy-
chiatric hospital beds has steadily declined in recent years, despite the lack 
of intensive intermediate care alternatives in the community. The design 
and implementation of intensive residential treatment programs are not 
currently guided by controlled studies, but these studies are necessary to 
determine the clinical and economic utility of such programs. We present 
clinical and outcome data on an initial sample of patients treated over the 
last 5 years.
Methods: Naturalistic, non-controlled assessment of symptomatic and 
functional outcome in an initial sample of young adults with persistent 
mental illnesses treated in a community-based residential program. Patients 
were treated with an individualized combination of modalities such as 
Illness Education and Management, Supported Employment, Individual, 
Group and Family Psychotherapies and Psychopharmacology. Standard 
clinical rating scales were used during the period of treatment and all dis-
charged patients were contacted on an annual basis in order to complete a 
survey of clinical outcome.
Results: 101 patients had been admitted and treated since the facility opened 
in October 2011. Median age of the patients was 25  years, mean illness 
duration was 12.6 years, and the mean number of prior hospitalizations 
was 6.5. Diagnostic distribution was: 36.7% psychotic disorders, 27.7% 
unipolar mood disorders, 19.8% bipolar mood disorders, 7.9% autism 
spectrum disorders, and 7.9% post-traumatic stress disorder or other anx-
iety conditions. 37% of residents met criteria for personality disorders, the 
majority of which was borderline personality disorder. 42% of residents 
also met criteria for a substance use disorder in the year prior to admission. 
Ratings on the Multnomah Community Ability Scale improved by 16%, 
ratings on the Brief  Psychiatric Rating Scale declined by 20% and ratings 
on the Montgomery-Asberg Depression Rating Scale declined by 37%. The 
average survey response rate after discharge was 59%. With regard to com-
munity engagement: 40.3% of current residents and 35.1% of discharged 
residents were competitively employed. 16.7% of current residents and 
17.8% of discharged residents worked as volunteers, and 23.3% of current 
residents and 26.3% of discharged residents were attending school. A sur-
vey of dispositions revealed that: 49.7% of discharged residents were liv-
ing independently, 14.9% were living with family, 2.2% were homeless, and 
5.4% had died from suicide. The hospitalization rate declined from 0.84/
year to 0.57/year before and after discharge.
Discussion: Long-term residential treatment for young adults with persist-
ent mental illness results in improved symptomatic recovery, independent 
living, increased employment rates, and reduced hospitalizations.
S203. COMPENSATORY COGNITIVE 
APPROACHES TO IMPROVING FUNCTIONING 
IN PSYCHOSIS: SYSTEMATIC REVIEW AND 
META-ANALYSIS
Kelly Allott*,1, Kristi van-der-EL2, Emma Parrish3,  
Chris Bowie4, Sean Kidd5, Susan McGurk6, Sarah Hetrick7, 
Shayden Bryce8, Matthew Hamilton2, Eoin Killackey1, 
Dawn Velligan9
1Orygen, The National Centre of Excellence in Youth Mental 
Health; 2Orygen, The National Centre of Excellence in Youth 
Mental Health, The University of Melbourne; 3Harvard Medical 
School at Beth Israel Deaconess Medical Center; 4Queen’s 
University; 5University of Toronto; 6Boston University; 7University 
of Auckland and Centre for Youth Mental Health, University of 
Melbourne; 8Monash University; 9University of Texas Health 
Science Center at San Antonio, School of Medicine
Background: Cognitive impairments in domains such as attention, mem-
ory, processing speed and executive functions are a central feature of 
psychotic disorders that have significant negative consequences for daily 
functioning, including activities of daily living, social and vocational roles. 
Compensatory approaches aim to minimise the impact of cognitive impair-
ment on daily functioning through the use of aids or strategies to reduce 
cognitive load, in much the same way as glasses reduce the impact of vision 
impairment. The primary treatment target is real world community func-
tioning and functional capacity, rather than cognition. There is now a need 
to synthesise the available evidence in this field so that treatment recom-
mendations and future research directions can be better informed. A large 
body of research into compensatory approaches to cognition in psychosis 
exists, but this has never been comprehensively synthesised. The aim of this 
systematic review and meta-analysis is to examine the effects of compensa-
tory approaches for cognitive deficits in psychotic disorders on i) functional 
outcomes and ii) other outcomes such as symptoms and quality of life.
Methods: A systematic review and meta-analysis was conducted according 
to PRISMA guidelines. PsycINFO and MEDLINE electronic databases 
were searched from inception to October 2017 using multiple terms for 
‘psychosis’, ‘cognition’ and ‘compensatory’. All papers retrieved from this 
search were double-screened and final inclusion/exclusion was determine by 
consensus. Data were double-extracted and risk of bias rated by two inde-
pendent authors. Meta-analysis only included randomised-controlled trials. 
Standardised Mean Differences (SMD) were calculated to produce a single 
summary estimate using the random-effects model with 95% Confidence 
Intervals using Comprehensive Meta-Analysis (CMA) software. When 
means or standard deviations were not reported in the original articles, 
SMDs were calculated from data provided by the study authors.
Results: 2192 articles were identified via electronic and manual searches. 
Forty-two papers describing 40 independent studies were included in 
the review: case studies (n=4), case series (n=2), uncontrolled single arm 
pilot studies (n=5), within-subjects designs (n=1), quasi-randomised tri-
als (n=2), and randomised controlled trials (n=26). The types of com-
pensatory interventions included environmental adaptation and supports, 
internal and external self-management strategies, and errorless learning. 
Compensatory interventions were associated with improvements in global 
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functioning post intervention (N=1,449; SMD=0.506; 95%CI=0.347, 
0.665; p<.001). Improvements in global symptoms (N=849; SMD=-0.297; 
95%CI=-0.484, -0.111; p=.002) and positive symptoms (N=784; SMD=-0.227; 
95%CI=-0.416, -0.038; p=.018) were also found. Compensatory interven-
tions were not associated with improvements in negative symptoms (N=736; 
SMD=-0.162; 95%CI=-0.382, 0.058; p=.150). The heterogeneity of find-
ings was low.
Discussion: Compensatory approaches are effective for improving func-
tioning in psychosis, with a medium effect size. General symptoms and 
positive symptoms appear to benefit from compensatory approaches, but 
compensatory approaches are not effective for improving negative symp-
toms. Future analyses will examine the durability of effects, effects of study 
quality and moderating factors such as pure vs. partially compensatory, 
treatment intensity/length, mode of delivery (group vs. individual), baseline 
functioning level and age of participants.
S204. NUTRITIONAL DEFICIENCIES AND 
CLINICAL CORRELATES IN FIRST-EPISODE 
PSYCHOSIS: A SYSTEMATIC REVIEW AND 
META-ANALYSIS
Joseph Firth*,1, Rebekah Carney2, Scott Teasdale3, 
Brendon Stubbs4, Philip Ward5, Michael Berk6, Jerome Sarris7
1University of Western Sydney; 2University of Manchester; 
3UNSW and SESLHD; 4Institute of Psychiatry, Psychology and 
Neuroscience King’s College London; 5UNSW; 6Deakin University, 
School of Medicine; 7NICM, University of Western Sydney
Background: Diet is increasingly recognised as a modifiable factor influenc-
ing the onset and outcomes of psychiatric disorders. Previous meta-analy-
ses of blood nutrient levels in schizophrenia have already shown significant 
reductions in various individual vitamins/minerals. However, studies to 
date have largely focused on individual nutrients, and only considered nutri-
ent status in patients with long-term schizophrenia. Meta-analytic evalua-
tion of the evidence for nutrient deficits in first-episode psychosis (FEP) 
is completely absent. Therefore, we conducted a systematic review of all 
published studies comparing blood levels of vitamins and/or mineral in 
FEP to healthy control samples; and applied meta-analytic techniques to 
determine the prevalence and extent of deficiencies across the full spectrum 
of nutrients examined in this population to date.
Methods: We searched electronic databases from inception to July 2017 
for all studies examining blood levels (i.e. serum, plasma or whole blood) 
of nutrient levels in people with FEP compared to healthy controls. Our 
systematic search identified 28 eligible studies, examining blood levels 
of 16 different nutrients (six vitamins, ten dietary minerals) across 2,612 
individuals: 1,221 patients with FEP and 1,391 control subjects. Random 
effects meta-analyses compared nutrient levels in FEP to healthy controls. 
Clinical correlates of nutritional status in patient samples were systemati-
cally reviewed.
Results: Random effects meta-analyses found that people with FEP had 
large, significant reductions in blood levels of vitamin B9 (i.e. folate) 
compared to healthy controls(N=6, n=827, g=-0.624, 95% C.I.=-1.176 
to -0.072, p=0.027). Significant reductions were also found for vitamin D 
(N=7, n=906, g=-1.055, 95% C.I.=-1.99 to -0.119, p=0.027) and, among 
fewer studies, vitamin C (N=2, n=96, g=-2.207, 95% C.I.=-3.71 to -0.71, 
p=0.004). No differences were found for other vitamins or minerals. 
Systematic synthesis of clinical correlates showed that reductions in both 
folate and vitamin D held significant relationships with greater psychiatric 
symptoms in FEP.
Discussion: This is the first meta-analysis to examine the prevalence, extent 
and clinical correlates of nutritional deficiencies in FEP to date. The deficits 
in vitamin D and folate which have previously been observed in long-term 
schizophrenia appear to exist from illness onset, even prior to antipsychotic 
treatment, and are associated with more severe symptoms. The extent and 
importance of these deficiencies suggests that routine screening for vitamin 
D and folate deficiencies should be considered in early intervention services. 
Furthermore, since our previous meta-analyses have shown that high-dose 
b-vitamin supplementation can reduce symptoms in long-term schizophre-
nia, this should now be investigated in FEP. The potential physical and psy-
chological benefits of vitamin D supplementation in early psychosis should 
also be explored. However, further research is needed to establish casual 
and mechanistic relationships between vitamin deficiencies, poor diet and 
the onset and outcomes of psychotic disorders.
S205. TRANSCRANIAL DIRECT CURRENT 
STIMULATION FOR SEVERE, PERSISTENT, 
TREATMENT-REFRACTORY AUDITORY 
HALLUCINATIONS IN SCHIZOPHRENIA
Parth Goyal*,1, Lakhan Kataria1, Chittaranjan Andrade2, 
Priyal Desai1
1SBKS MI&RC; 2NIMHANS, Bengaluru
Background: Up to 25% of schizophrenia patients continue to experience 
distressing auditory hallucinations despite best efforts at treatment with 
antipsychotic drugs. Transcranial direct current stimulation (tDCS) has 
been suggested to rapidly attenuate such persistent hallucinations.
Methods: We treated 23 schizophrenia patients with persistent, antipsy-
chotic-refractory auditory hallucinations using tDCS in a single-group, 
open-label design. tDCS was administered at 2 mA current intensity for 
20  min, twice-daily and 4  h apart, across 5 consecutive days; the anode 
was placed over the the left dorsolateral prefrontal cortex and the cath-
ode over the left temporoparietal junction. Ongoing antipsychotic medica-
tions were continued unchanged. Patients were assessed using the Auditory 
Hallucinations Rating Scale (AHRS) at treatment endpoint and at 1- and 
3-month follow up. Response was defined as 50% or greater attenuation in 
AHRS scores.
Results: All patients completed the study. tDCS resulted in substantial 
improvement. Mean (standard deviation) AHRS scores dropped from 
29.0(8.3) at baseline to 4.4(5.6) at treatment endpoint; these values were 
9.3(9.3) and 7.8(8.4) at 1- and 3-months follow up. The response rate was 
91.3%, 69.6%, and 82.6% at the 3 posttreatment assessment points, respec-
tively. Complete remission of hallucinations (AHRS=0) was observed in 
61%, 44%, and 44% at the 3 posttreatment assessment points. tDCS was 
very well tolerated and adverse effects were minimal.
Discussion: tDCS is effective and well tolerated in schizophrenia patients 
with persistent, antipsychotic-refractory auditory hallucinations. In most 
patients, the benefits last for up to 3 months or longer.
S206. KNOWLEDGE ABOUT CAUSES OF 
RELAPSE DURING PSYCHOEDUCATION IN 
PATIENTS LIVING WITH SCHIZOPHRENIA- 
A QUALITATIVE ANALYSIS
Anoop Gupta*,1, Mamidipalli Spoorthy2, Bina Gurung1, 
Robin Jha1, Bishnu Acharya1
1National Medical College; 2All India Institute of Medical Sciences, 
Raipur
Background: Evidence till date shows different reasons of relapse in schiz-
ophrenia around the world. However, there was almost no reliable data 
from Nepal. We want to report a thematic study based on the reports of 12 
patients living with schizophrenia and their family members. These patients 
were approached during psychoeducation group sessions.
Methods: Twelve patients with a diagnosis of  schizophrenia as per 
Diagnostic and Statistical Manual of  mental disorders-5 criteria, who 
were accompanied by their family members were selected. A minimum 
